Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Calling the shots [[electronic resource] ] : immunization finance policies and practices / / Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine
| Calling the shots [[electronic resource] ] : immunization finance policies and practices / / Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 2000 |
| Descrizione fisica | 1 online resource (332 p.) |
| Disciplina | 614.4/7/0973 |
| Soggetto topico |
Immunization - Government policy - United States
Immunization of children - Government policy - United States Immunization - United States - Finance Immunization - United States - Planning Medicine, Preventive - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-50136-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover""; ""Front Matter""; ""INDEPENDENT REPORT REVIEWERS""; ""Preface""; ""Contents""; ""Boxes, Tables, and Figures""; ""Executive Summary""; ""1 Introduction""; ""2 Change and Complexity in the National Immunization System""; ""3 Financing Vaccine Purchase and Delivery""; ""4 Building, Monitoring, and Sustaining Immunization Capacity""; ""5 Immunization Finance Policies and Practices""; ""6 Summary Findings, Conclusions, and Recommendations""; ""References""; ""Appendixes""; ""Appendix A Public Health Services Act, Section 317""; ""Appendix B Immunization Time-Line""
""Appendix C List of Contributors""""Appendix D Overview of State Survey""; ""Appendix E Overview of Case Studies and Site Visits""; ""Appendix F Annual Section 317 Awards to States, 1995�1999""; ""Appendix G State Immunization Requirements for School Children""; ""Appendix H Committee and Staff Biographies""; ""Index"" |
| Record Nr. | UNINA-9910456353503321 |
| Washington, D.C., : National Academy Press, 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Calling the shots [[electronic resource] ] : immunization finance policies and practices / / Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine
| Calling the shots [[electronic resource] ] : immunization finance policies and practices / / Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 2000 |
| Descrizione fisica | 1 online resource (332 p.) |
| Disciplina | 614.4/7/0973 |
| Soggetto topico |
Immunization - Government policy - United States
Immunization of children - Government policy - United States Immunization - United States - Finance Immunization - United States - Planning Medicine, Preventive - United States |
| ISBN |
0-309-17195-4
0-309-50136-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover""; ""Front Matter""; ""INDEPENDENT REPORT REVIEWERS""; ""Preface""; ""Contents""; ""Boxes, Tables, and Figures""; ""Executive Summary""; ""1 Introduction""; ""2 Change and Complexity in the National Immunization System""; ""3 Financing Vaccine Purchase and Delivery""; ""4 Building, Monitoring, and Sustaining Immunization Capacity""; ""5 Immunization Finance Policies and Practices""; ""6 Summary Findings, Conclusions, and Recommendations""; ""References""; ""Appendixes""; ""Appendix A Public Health Services Act, Section 317""; ""Appendix B Immunization Time-Line""
""Appendix C List of Contributors""""Appendix D Overview of State Survey""; ""Appendix E Overview of Case Studies and Site Visits""; ""Appendix F Annual Section 317 Awards to States, 1995�1999""; ""Appendix G State Immunization Requirements for School Children""; ""Appendix H Committee and Staff Biographies""; ""Index"" |
| Record Nr. | UNINA-9910778630203321 |
| Washington, D.C., : National Academy Press, 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Calling the shots : immunization finance policies and practices / / Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine
| Calling the shots : immunization finance policies and practices / / Committee on Immunization Finance Policies and Practices, Division of Health Care Services and Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 2000 |
| Descrizione fisica | 1 online resource (332 p.) |
| Disciplina | 614.4/7/0973 |
| Soggetto topico |
Immunization - Government policy - United States
Immunization of children - Government policy - United States Immunization - United States - Finance Immunization - United States - Planning Medicine, Preventive - United States |
| ISBN |
9780309171953
0309171954 9780309501361 0309501369 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Cover""; ""Front Matter""; ""INDEPENDENT REPORT REVIEWERS""; ""Preface""; ""Contents""; ""Boxes, Tables, and Figures""; ""Executive Summary""; ""1 Introduction""; ""2 Change and Complexity in the National Immunization System""; ""3 Financing Vaccine Purchase and Delivery""; ""4 Building, Monitoring, and Sustaining Immunization Capacity""; ""5 Immunization Finance Policies and Practices""; ""6 Summary Findings, Conclusions, and Recommendations""; ""References""; ""Appendixes""; ""Appendix A Public Health Services Act, Section 317""; ""Appendix B Immunization Time-Line""
""Appendix C List of Contributors""""Appendix D Overview of State Survey""; ""Appendix E Overview of Case Studies and Site Visits""; ""Appendix F Annual Section 317 Awards to States, 1995�1999""; ""Appendix G State Immunization Requirements for School Children""; ""Appendix H Committee and Staff Biographies""; ""Index"" |
| Record Nr. | UNINA-9910969866403321 |
| Washington, D.C., : National Academy Press, 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of importance in the United States [[electronic resource] /] / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
| Diseases of importance in the United States [[electronic resource] /] / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (472 p.) |
| Disciplina | 614.4/7/0973 |
| Collana | New vaccine development : establishing priorities |
| Soggetto topico |
Vaccines - Research - Government policy
Vaccination - United States Vaccination - Developing countries |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-30039-X
9786611300395 0-309-11575-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Title""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Abstract""; ""Contents""; ""1 Summary""; ""Selection of Candidates""; ""Determination of Health Benefits""; ""Disease Burden Estimates""; ""Infant Mortality Equivalence Values""; ""Total Disease Burden Values""; ""Vaccine Characteristics""; ""Predictions of Vaccine Development""; ""Definition of Probable Vaccine Target Population""; ""Estimation of Vaccine Utilization""; ""Estimation of Time to Licensure, Time to vaccine Adoption, and Delay of Vaccination Benefits: Discounting""; ""Estimation of vaccine Preventable Illness""
""Calculation of Expected Health Benefits for Each Vaccine""""Cost Calculations""; ""Calculation of Morbidity Costs Averted by the Vaccine""; ""Vaccination Program Costs""; ""Integration of Costs""; ""Interpretation of Health Benefit and Net Cost Rankings""; ""Findings, Conclusions, Recommendations""; ""Recommendation""; ""Reference""; ""2 Priority Setting for Health Related Investments: A Review of Methods""; ""Methods for Project Ranking and Selection""; ""Multiattribute Accounting""; ""Multiattribute Scoring""; ""Decision Analysis With Multiple Objectives"" ""Cost-Effectiveness and Cost-Utility Analysis""""Benefit-Cost Analysis""; ""Selection of an Approach""; ""Issues in Project Ranking Methodologies""; ""Sources of Estimates""; ""Sequential or “Lexicographic� Methods""; ""Interdependence Among Projects""; ""The “Portfolio� Question""; ""Summary""; ""References""; ""3 Overview of the Analytic Approach""; ""Method""; ""Interpretation of Results""; ""Guidelines""; ""Definition of Dominance""; ""Step 1""; ""Step 2""; ""Step 3""; ""Step 4""; ""Summary""; ""4 Comparison of Disease Burdens and Costs"" ""Elements of the System for Comparing Morbidity and Mortality Burdens Arising From various Diseases""""Trade-Off Values""; ""Expression of Morbidity and Mortality Burdens""; ""Procedures Used in Deriving Disease Estimates""; ""Limitations of the Current Estimates""; ""Value Judgments in Quantifying Morbidity and Mortality""; ""IME Perspectives used in This Study""; ""The Effect of Adopting Other IME Perspectives""; ""Comparison of Direct Costs Resulting from Diseases""; ""Scope of Cost Calculations""; ""Procedures""; ""Findings""; ""Limitations of the Proposed System"" ""Summary and Conclusions""""Recommendations""; ""References""; ""5 Predictions on Vaccine Development""; ""The Need for Predictions""; ""Selection of Candidates""; ""Vaccine Candidates and Target Populations""; ""Predictions on Vaccine Development""; ""Probability of Successful Development""; ""Cost of Development""; ""Time to Licensure""; ""Comments""; ""Predictions on Vaccine Characteristics""; ""Efficacy""; ""Adverse Reactions""; ""Production Technology, Delivery Requirements, and Cost/Dose""; ""Number of Doses and Route of Administration""; ""Conclusions"" ""6 Assessing the Likely Utilization of New Vaccines"" |
| Record Nr. | UNINA-9910456246503321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of importance in the United States / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
| Diseases of importance in the United States / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (472 pages) |
| Disciplina | 614.4/7/0973 |
| Collana | New vaccine development : establishing priorities |
| Soggetto topico |
Vaccines - Research - Government policy
Vaccination - United States Vaccination - Developing countries |
| ISBN |
1-281-30039-X
9786611300395 0-309-11575-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Title""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Abstract""; ""Contents""; ""1 Summary""; ""Selection of Candidates""; ""Determination of Health Benefits""; ""Disease Burden Estimates""; ""Infant Mortality Equivalence Values""; ""Total Disease Burden Values""; ""Vaccine Characteristics""; ""Predictions of Vaccine Development""; ""Definition of Probable Vaccine Target Population""; ""Estimation of Vaccine Utilization""; ""Estimation of Time to Licensure, Time to vaccine Adoption, and Delay of Vaccination Benefits: Discounting""; ""Estimation of vaccine Preventable Illness""
""Calculation of Expected Health Benefits for Each Vaccine"" ""Cost Calculations""; ""Calculation of Morbidity Costs Averted by the Vaccine""; ""Vaccination Program Costs""; ""Integration of Costs""; ""Interpretation of Health Benefit and Net Cost Rankings""; ""Findings, Conclusions, Recommendations""; ""Recommendation""; ""Reference""; ""2 Priority Setting for Health Related Investments: A Review of Methods""; ""Methods for Project Ranking and Selection""; ""Multiattribute Accounting""; ""Multiattribute Scoring""; ""Decision Analysis With Multiple Objectives"" ""Cost-Effectiveness and Cost-Utility Analysis"" ""Benefit-Cost Analysis""; ""Selection of an Approach""; ""Issues in Project Ranking Methodologies""; ""Sources of Estimates""; ""Sequential or 'Lexicographic' Methods""; ""Interdependence Among Projects""; ""The 'Portfolio' Question""; ""Summary""; ""References""; ""3 Overview of the Analytic Approach""; ""Method""; ""Interpretation of Results""; ""Guidelines""; ""Definition of Dominance""; ""Step 1""; ""Step 2""; ""Step 3""; ""Step 4""; ""Summary""; ""4 Comparison of Disease Burdens and Costs"" ""Elements of the System for Comparing Morbidity and Mortality Burdens Arising From various Diseases"" ""Trade-Off Values""; ""Expression of Morbidity and Mortality Burdens""; ""Procedures Used in Deriving Disease Estimates""; ""Limitations of the Current Estimates""; ""Value Judgments in Quantifying Morbidity and Mortality""; ""IME Perspectives used in This Study""; ""The Effect of Adopting Other IME Perspectives""; ""Comparison of Direct Costs Resulting from Diseases""; ""Scope of Cost Calculations""; ""Procedures""; ""Findings""; ""Limitations of the Proposed System"" ""Summary and Conclusions"" ""Recommendations""; ""References""; ""5 Predictions on Vaccine Development""; ""The Need for Predictions""; ""Selection of Candidates""; ""Vaccine Candidates and Target Populations""; ""Predictions on Vaccine Development""; ""Probability of Successful Development""; ""Cost of Development""; ""Time to Licensure""; ""Comments""; ""Predictions on Vaccine Characteristics""; ""Efficacy""; ""Adverse Reactions""; ""Production Technology, Delivery Requirements, and Cost/Dose""; ""Number of Doses and Route of Administration""; ""Conclusions""; ""6 Assessing the Likely Utilization of New Vaccines"" |
| Record Nr. | UNINA-9910780901103321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||